Mucosal priming alters pathogenesis of Rift Valley fever.
Anderson
A O
AO
Laboratory of Respiratory and Mucosal Immunity, USAMRIID, Ft. Detrick, Frederick, MD 21701-5011.
Snyder
L F
LF
Pitt
M L
ML
Wood
O L
OL
D000284:Administration, Oral; D000336:Aerosols; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000956:Antigens, Viral / Q000032:analysis; D004660:Encephalitis / Q000276:immunology / Q000382:microbiology; D007071:Immunoglobulin A, Secretory / Q000276:immunology; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007413:Intestinal Mucosa / Q000276:immunology*; D008099:Liver / Q000276:immunology; D051379:Mice; D012295:Rift Valley Fever / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D012296:Rift Valley fever virus / Q000276:immunology / Q000472:pathogenicity; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
D000336:Aerosols; D000914:Antibodies, Viral; D000956:Antigens, Viral; D007071:Immunoglobulin A, Secretory; D014613:Vaccines, Attenuated; D014765:Viral Vaccines